Vanguard Global Advisers »

Eledon Pharmaceuticals shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Eledon Pharmaceuticals (ELDN) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Eledon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eledon Pharmaceuticals held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eledon Pharmaceuticals by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $69k 22k 3.08

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Eledon Pharmaceuticals

BVF
BlackRock
Vanguard Group
Vanguard Capital Management
Ensign Peak Advisors
Blue Owl Capital Holdings
Zimmer Partners
Geode Capital Management
Sphera Funds Management
Catalio Capital Management
AWM Investment Company
Leucadia National Corporation
Kingdon Capital Management
ADAR1 Capital Management
Stonepine Capital Management

View all funds holding Eledon Pharmaceuticals